DMTRF (3-D Matrix) Current Deferred Revenue: $0.00 Mil (As of Jan. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DMTRF 3-D Matrix Ltd DMTRF
56 GF Score
Price $2.50
GF Value $2.17
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is 3-D Matrix Current Deferred Revenue?

3-D Matrix DMTRF 56 Current Deferred Revenue is $0.00 Mil as of Jan. 2026. GuruFocus rates DMTRF with a GF Score™ of 56/100 and a GF Value™ of $2.17 (Modestly Overvalued). The stock has 3 warning signs investors should review.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

3-D Matrix's current deferred revenue for the quarter that ended in Jan. 2026 was $0.00 Mil.

3-D Matrix Current Deferred Revenue Related Terms

3-D Matrix Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for 3-D Matrix's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

3-D Matrix Current Deferred Revenue Chart

3-D Matrix Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

3-D Matrix Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
DMTRF
56GF Score
3-D Matrix Ltd DMTRF
Current Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Revenue of $0.00 Mil mean?
3-D Matrix (DMTRF) has a Current Deferred Revenue of $0.00 Mil as of Jan. 2026. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on 3-D Matrix and its competitors.
Is 3-D Matrix's Current Deferred Revenue too high?
3-D Matrix's current Current Deferred Revenue is $0.00 Mil. Overall, 3-D Matrix has a GF Score™ of 56/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does 3-D Matrix's Current Deferred Revenue compare to ABT and SYK?
3-D Matrix's Current Deferred Revenue of $0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Medical Devices & Instruments company?
A good Current Deferred Revenue depends on the Medical Devices & Instruments industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on 3-D Matrix and its competitors. 3-D Matrix's current Current Deferred Revenue is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 3-D Matrix stock overvalued right now?
Based on GuruFocus' analysis, 3-D Matrix (DMTRF) is currently considered Modestly Overvalued. The stock's GF Value™ is $2.17, compared to a current price of $2.50 — trading 15.2% above its estimated fair value. The current Current Deferred Revenue is $0.00 Mil. 3-D Matrix's overall GF Score™ is 56/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For 3-D Matrix (DMTRF), the current Current Deferred Revenue is $0.00 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is 3-D Matrix (DMTRF) Overvalued in 2026?

Based on GuruFocus' analysis, 3-D Matrix stock appears to be overvalued. The current stock price of $2.50 is trading 15.2% above its estimated GF Value™ of $2.17. GuruFocus considers 3-D Matrix to be Modestly Overvalued.

Key valuation signals for DMTRF:

  • Current Deferred Revenue: $0.00 Mil
  • GF Value™: $2.17 vs. price of $2.50 (15.2% above fair value)
  • GF Score™: 56/100 with 3 warning signs

No single metric tells the full story. See the DMTRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

3-D Matrix Business Description

Other Exchanges 7777:Japan
Address 3-2-4 Kojimachi, Chiyoda-ku, 7th floor, Kojimachi HF Building, Tokyo, JPN, 102-0083
3-D Matrix Ltd is engaged in the research, development, manufacture, and sale of medical devices based on the self-assembling peptide technology. Its products include PuraMatrix, High Concentration PuraMatrix, Modified Peptide and GMP Grade PuraMatrix.
56GF Score

Get the complete analysis for DMTRF

Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.50
Price
$2.17
GF Value